Previous close | 241.89 |
Open | 244.37 |
Bid | 239.43 x 1100 |
Ask | 239.39 x 800 |
Day's range | 238.65 - 245.09 |
52-week range | 189.53 - 319.32 |
Volume | 10,619,303 |
Avg. volume | 17,910,337 |
Market cap | 644.253B |
Beta (5Y monthly) | 0.82 |
PE ratio (TTM) | 27.06 |
EPS (TTM) | 8.85 |
Earnings date | 20 May 2021 - 24 May 2021 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 315.94 |
BABA, BIOL, CTK, GOL, and JKS have been added to the Zacks Rank #5 (Strong Sell) List on April 14, 2021
The contours of a possible truce between Beijing and Jack Ma’s internet empire are beginning to take shape, with the Chinese billionaire’s ecommerce flagship Alibaba faring better than its sister fintech unit Ant Group. China’s central bank, which has been leading the clampdown on Ant since its record $37bn initial public offering was abruptly halted in November, this week outlined the terms of a “rectification” of the fintech’s operations. The plan will have big repercussions for both Alipay, China’s most popular online payments app, and Ant’s huge consumer lending business.
Alibaba (BABA) closed at $241.89 in the latest trading session, marking a -0.87% move from the prior day.